About
99.76AUD-0.29 -0.29%
Closed • Updated at 17:39 GMT+00:00Market Cap$34.23B
P/E Ratio22.25
Volume2.07M
Beta0.77
RSI22.66
Gross Margin48.62%
Csl Limited — investor relations, events, news, and company updates on 6ix.
Latest News
May 14 2026
Vaccine Adjuvant Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | CSL Limited, Seppic
May 11 2026
Interim CEO 90 Day Review and Financial Update
Mar 9 2026
CSL announces expansion of Illinois plasma therapy manufacturing facility
Mar 6 2026
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
Feb 11 2026
CSL Half Year Results Investor Presentation
Translate